Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Reduced Intensity Double Umbilical Cord Blood Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL
- Status
- COMPLETED
- Phase
- PHASE1
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Facing Obstacles to RDI (Relative Dose Intensity) Through Telephone Intervention Strategy
- Status
- COMPLETED
- Phase
- NA
Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine
- Status
- COMPLETED
- Phase
- PHASE2
Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Unrelated Donor Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor
- Status
- COMPLETED
- Phase
- PHASE2
Genomic Analysis of Patients With Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
- Status
- TERMINATED
- Phase
- PHASE1